COVID-19-Associated Hospitalizations Among U.S. Adults Aged ≥18 Years - COVID-NET, 12 States, October 2023-April 2024.

IF 25.4 1区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

MMWR. Morbidity and mortality weekly report Pub Date : 2024-10-03 DOI:10.15585/mmwr.mm7339a2

Christopher A Taylor, Kadam Patel, Huong Pham, Pam Daily Kirley, Breanna Kawasaki, James Meek, Lucy Witt, Patricia A Ryan, Libby Reeg, Kathy Como-Sabetti, Adrienne Domen, Bridget Anderson, Sophrena Bushey, Melissa Sutton, H Keipp Talbot, Emma Mendez, Fiona P Havers

{"title":"COVID-19-Associated Hospitalizations Among U.S. Adults Aged ≥18 Years - COVID-NET, 12 States, October 2023-April 2024.","authors":"Christopher A Taylor, Kadam Patel, Huong Pham, Pam Daily Kirley, Breanna Kawasaki, James Meek, Lucy Witt, Patricia A Ryan, Libby Reeg, Kathy Como-Sabetti, Adrienne Domen, Bridget Anderson, Sophrena Bushey, Melissa Sutton, H Keipp Talbot, Emma Mendez, Fiona P Havers","doi":"10.15585/mmwr.mm7339a2","DOIUrl":null,"url":null,"abstract":"<p><p>Among adults, COVID-19 hospitalization rates increase with age. Data from the COVID-19-Associated Hospitalization Surveillance Network were analyzed to estimate population-based COVID-19-associated hospitalization rates during October 2023-April 2024 and identify demographic and clinical characteristics of adults aged ≥18 years hospitalized with COVID-19. Adults aged ≥65 years accounted for 70% of all adult COVID-19-associated hospitalizations, and their COVID-19-associated hospitalization rates were higher than those among younger adult age groups. Cumulative rates of COVID-19-associated hospitalization during October 2023-April 2024 were the lowest for all adult age groups during an October-April surveillance period since 2020-2021. However, hospitalization rates among all adults aged ≥75 years approached one COVID-19-associated hospitalization for every 100 persons. Among adults hospitalized with COVID-19, 88.1% had not received the 2023-2024 formula COVID-19 vaccine before hospitalization, 80.0% had multiple underlying medical conditions, and 16.6% were residents of long-term care facilities (LTCFs). Guidance for adults at high risk for severe COVID-19 illness, including adults aged ≥65 years and residents of LTCFs, should continue to focus on adopting measures to reduce risk for contracting COVID-19, advocating for receipt of recommended COVID-19 vaccinations, and seeking prompt outpatient antiviral treatment after receipt of a positive SARS-CoV-2 test result.</p>","PeriodicalId":18637,"journal":{"name":"MMWR. Morbidity and mortality weekly report","volume":"73 39","pages":"869-875"},"PeriodicalIF":25.4000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449267/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MMWR. Morbidity and mortality weekly report","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15585/mmwr.mm7339a2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Among adults, COVID-19 hospitalization rates increase with age. Data from the COVID-19-Associated Hospitalization Surveillance Network were analyzed to estimate population-based COVID-19-associated hospitalization rates during October 2023-April 2024 and identify demographic and clinical characteristics of adults aged ≥18 years hospitalized with COVID-19. Adults aged ≥65 years accounted for 70% of all adult COVID-19-associated hospitalizations, and their COVID-19-associated hospitalization rates were higher than those among younger adult age groups. Cumulative rates of COVID-19-associated hospitalization during October 2023-April 2024 were the lowest for all adult age groups during an October-April surveillance period since 2020-2021. However, hospitalization rates among all adults aged ≥75 years approached one COVID-19-associated hospitalization for every 100 persons. Among adults hospitalized with COVID-19, 88.1% had not received the 2023-2024 formula COVID-19 vaccine before hospitalization, 80.0% had multiple underlying medical conditions, and 16.6% were residents of long-term care facilities (LTCFs). Guidance for adults at high risk for severe COVID-19 illness, including adults aged ≥65 years and residents of LTCFs, should continue to focus on adopting measures to reduce risk for contracting COVID-19, advocating for receipt of recommended COVID-19 vaccinations, and seeking prompt outpatient antiviral treatment after receipt of a positive SARS-CoV-2 test result.

查看原文本刊更多论文

2023 年 10 月至 2024 年 4 月，12 个州 COVID-NET 中年龄≥18 岁的美国成人 COVID-19 相关住院情况。

在成年人中，COVID-19 的住院率随着年龄的增长而增加。我们分析了COVID-19相关住院监测网络的数据，以估算2023年10月至2024年4月期间基于人群的COVID-19相关住院率，并确定因COVID-19住院的≥18岁成人的人口统计学和临床特征。年龄≥65岁的成人占所有COVID-19相关成人住院人数的70%，他们的COVID-19相关住院率高于较年轻的成人年龄组。在 2023 年 10 月至 2024 年 4 月期间，COVID-19 相关的累计住院率是自 2020-2021 年以来所有成人年龄组在 10 月至 4 月监测期间的最低值。然而，在所有年龄≥75 岁的成人中，住院率接近每 100 人中就有 1 例 COVID-19 相关住院病例。在因 COVID-19 而住院的成年人中，88.1% 在住院前未接种过 2023-2024 年配方的 COVID-19 疫苗，80.0% 有多种基础疾病，16.6% 是长期护理机构 (LTCF) 的居民。对 COVID-19 重症高危成人（包括年龄≥65 岁的成人和长期护理设施的居民）的指导应继续侧重于采取措施降低感染 COVID-19 的风险，提倡接种推荐的 COVID-19 疫苗，以及在收到 SARS-CoV-2 检测阳性结果后及时寻求门诊抗病毒治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

MMWR. Morbidity and mortality weekly report PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -

CiteScore

65.40

自引率

0.90%

发文量

309

期刊介绍： The Morbidity and Mortality Weekly Report (MMWR ) series is prepared by the Centers for Disease Control and Prevention (CDC). Often called “the voice of CDC,” the MMWR series is the agency’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominantly consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.